Description
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Cas No. | 1168091-68-6 |
---|---|
Purity | ≥98% |
Formula | C16H14FIN4O3 |
Formula Wt. | 456.21 |
IUPAC Name | 5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide |
Solubility | DMSO 91 mg/mL warmed (199.46 mM) Ethanol 5 mg/mL warmed (10.95 mM) Water Insoluble |
Appearance | Beige Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Hatzivassiliou G, Haling JR, Chen H, et al. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature. 2013 Sep 12;501(7466):232-6. PMID: 23934108.
ET-A/B antagonist.
Thienylbutyl ITC analog.
Degrades of BET proteins.
Inhibitor of PI3K.
Tetrapeptide, binds cell surface integrins.
BH3 mimetic; Bcl-2, Bxl-xl, Bcl-w inhibitor.
Endogenous glycoprotein; lactoferrin agonist.
NSAID; COX-1/2 inhibitor.
BTK inhibitor.
Found in Aristolochia and Radix; potential PLA2...
Stem cell neurogenesis inducer.
Neuropeptide found in Schistocera gregaria.
Caspase 3 substrate.
c-MET, Tie-2, VEGFR inhibitor.
Peptide, involved in neutrophil activation; FPR...
VEGF-C/Nrp2 inhibitor. Leukotriene receptor ant...
Cephalosporin analogue
Potential p53 activator or SIRT2 inhibitor.
SYK/JAK inhibitor
Penicillin derivative, chelating agent; carboxy...